CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 251 filers reported holding CYTOKINETICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,750 | -12.9% | 297 | -3.6% | 0.00% | 0.0% |
| Q2 2023 | $10,047 | +10.7% | 308 | +19.4% | 0.00% | 0.0% |
| Q1 2023 | $9,079 | -54.0% | 258 | -40.1% | 0.00% | -50.0% |
| Q4 2022 | $19,748 | -31.9% | 431 | -27.9% | 0.00% | -60.0% |
| Q3 2022 | $29,000 | +52.6% | 598 | +22.5% | 0.01% | +66.7% |
| Q2 2022 | $19,000 | +18.8% | 488 | +13.0% | 0.00% | +50.0% |
| Q1 2022 | $16,000 | +128.6% | 432 | +188.0% | 0.00% | +100.0% |
| Q4 2021 | $7,000 | +250.0% | 150 | +200.0% | 0.00% | 0.0% |
| Q3 2021 | $2,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |